<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Efficacy of amiodarone in rate control for atrial fibrillation</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Efficacy of amiodarone in rate control for atrial fibrillation</h1>
<div class="graphic"><div class="figure"><div class="ttl">Efficacy of amiodarone in rate control for atrial fibrillation</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_lgnd">Effect of intravenous placebo, amiodarone, and flecainide on the ventricular response to atrial fibrillation in patients who failed to revert to sinus rhythm after the initiation of therapy. Amiodarone slowed the ventricular response, an effect that was not seen with flecainide or placebo. Although flecainide was less effective for rate control, it was associated with earlier reversion to sinus rhythm than amiodarone or placebo. Note that the time scale is nonlinear.</div><div class="graphic_reference">Data from Donovan KD, Power BM, Hockings GE, et al. Am J Cardiol 1995; 75:693.</div><div id="graphicVersion">Graphic 81119 Version 3.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
